.png)
BioPharma Unscripted!
BioPharma Unscripted! connects leaders across biotech, pharma and healthcare to share insights that bridge US and European markets. Hosted by Marcus Metcalfe, this podcast brings together emerging biotech leaders, market access specialists and industry innovators to explore the challenges and opportunities in bringing life-changing treatments to patients.
Each episode features thought-provoking conversations with industry experts who share their journeys, strategies and practical advice on navigating market access, health economics and the complex healthcare landscape. With a focus on both interim leadership solutions and permanent placements, Marcus brings his relationship-driven approach to deliver valuable insights for professionals at all stages of their career.
Whether you're part of an emerging biotech company, an established pharmaceutical organisation or somewhere in between, this podcast offers a wealth of knowledge on building teams, developing market strategies and driving healthcare innovation forward. Join Marcus as he bridges the gap between US and European markets, providing a platform where science meets business strategy and technical expertise meets human connection.
Subscribe now for weekly episodes featuring the brightest minds in biotech and pharmaceutical market access.
BioPharma Unscripted!
European Market Access Strategy: Navigate the Joint Clinical Assessment | BioPharma Unscripted! Ep.1
European Market Access Strategy: Navigating the Joint Clinical Assessment | Elucid8 Podcast Ep.1
Join Marcus Metcalfe speaking with Martin Gisby about European market access and the upcoming Joint Clinical Assessment (JCA) launching January 2025.
Martin explains successful market access strategies in Europe, emphasising demonstrating comparative effectiveness versus standard of care. He offers practical guidance on the changing regulatory landscape for pharmaceutical companies planning European market entry.
In this episode:
- Demonstrating comparative effectiveness for European market access
- Impact of the European Joint Clinical Assessment in 2025
- Navigating multiple standards of care across European markets
- Recommendations for approaching European market entry
- Balancing regulatory and market access strategies
Chapters:
00:00 Introduction
01:20 Market access considerations
04:07 Introduction to JCA
05:10 Purpose and implementation
08:05 Focus on oncology medicines
09:40 Considerations for pharma companies
12:00 Strategic approaches
14:25 Multiple standards of care
16:40 Recommendations for early-stage companies
Connect with Marcus and Elucid8: https://www.linkedin.com/in/marcus-metcalfe-8938a35/ Marcus helps US & European Biotech & Pharmaceutical clients by providing Interim/Fractional & Advisory consultants for operational & strategic needs.
I also work selective Executive Search (perm) projects.
I have helped Clients when there is no headcount, when they can't find the right permanent candidate, when they have a spike in business, as an alternative to an external vendor or for those simply needing an extra pair of hands.
If you need a partner with an extensive network in HEOR and Market Access - this is his sweet spot.
He has placed over 120 HEOR and Market Access candidates during my time across US and Europe.
With his business partners, he covers the below functional areas.
• Biometrics • Business Development
• Clinical Research • Drug safety & Product safety
• Engineering • Health Economics
• Medical Affairs • Market Access
• Regulatory Affairs • Compliance/Quality Assurance
• Marketing & Medical • Scientific & Preclinical
• Communications
Sponsor Message
This episode is brought to you by www.elucid8.co - Connecting Talent, Strategy, and Investment to Transform Life Sciences
Podcast produced by www.podforge.co.uk